Research Summary
Analyzed using Evidence Intelligence™

Centella asiatica shows no significant glycemic improvement in type 2 diabetes

Last updated July 1, 2026

Key finding

An unadjusted between-group difference in HbA1c was observed (p = 0.006)

This study evaluated the safety and efficacy of Centella asiatica as a dietary supplement for glycemic control in individuals with type 2 diabetes, finding a significant reduction in HbA1c levels.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Save this study and add notes to your research library.

Plain-language summary

What this paper says

A plain-language read of the study's main message and where it applies.

Study focus

This study evaluated the safety and efficacy of Centella asiatica as a dietary supplement for glycemic control in individuals with type 2 diabetes, finding a significant reduction in HbA1c levels.

Clinical relevance

These findings suggest that Centella asiatica could be a beneficial dietary supplement for managing glycemic control in type 2 diabetes, potentially offering an additional strategy for patients seeking to improve their blood sugar levels and overall health.

Keep in mind

The study's sample size may limit the generalizability of the findings. The duration of the intervention may not reflect long-term effects. The study did not measure other potential confounding factors.

Published in

Journal Reference

Publication details and source links for this paper.

Weeratian T, Auemphon M, Tharin P, Doungkamol S. Safety and Efficacy of Centella asiatica as a Dietary Supplement for Glycemic Control in Type 2 Diabetes. Frontiers in Pharmacology. 2025;16:1680647. doi:10.3389/fphar.2025.1680647

Main Effects

Centella asiatica significantly reduced HbA1c levels by -0.14% (p = 0.006).

No significant differences were found in fasting plasma glucose between groups.

LDL cholesterol levels showed no significant change (p = 0.536).

Centella asiatica was well tolerated with mild gastrointestinal symptoms reported in 14.7% of participants.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Centella asiatica (CA) extract and Adverse events incidence, Fasting Plasma Glucose (FPG), HbA1c, and 1 more.

Primary intervention

Centella asiatica (CA) extract

Primary outcomes

  • Adverse events incidence
  • Fasting Plasma Glucose (FPG)
  • HbA1c

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

4
Evidence pairs
4
Relationships
3
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 72

3

Related topics

4

Evidence pairs

293

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 4 evidence relationships
  • Includes primary outcome data
  • Linked to 3 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Core evidence

Study findings

The primary outcomes reported in this study.

Adverse events incidence

Centella asiatica (CA) extract → Adverse events incidence

Centella asiatica (CA) extract → Adverse events incidence

Evidence Intelligence™
ImpactScore™
100
Very Positive
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Unlock full evidence details

Fasting Plasma Glucose (FPG)

Centella asiatica (CA) extract → Fasting Plasma Glucose (FPG)

Centella asiatica (CA) extract → Fasting Plasma Glucose (FPG)

Evidence Intelligence™
ImpactScore™
50
Neutral
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Unlock full evidence details

HbA1c

Centella asiatica (CA) extract → HbA1c

Centella asiatica (CA) extract → HbA1c

Evidence Intelligence™
ImpactScore™
50
Neutral
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Unlock full evidence details

LDL cholesterol

Centella asiatica (CA) extract → LDL cholesterol

Centella asiatica (CA) extract → LDL cholesterol

Evidence Intelligence™
ImpactScore™
50
Neutral
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Unlock full evidence details

Unlock full evidence analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

Evidence Suggest

  • Centella asiatica reduced HbA1c levels significantly (p = 0.006).
  • No changes in fasting plasma glucose were observed.
  • LDL cholesterol levels remained unchanged (p = 0.536).
who this applies

Who this applies to

  • Adults diagnosed with type 2 diabetes.
  • Individuals seeking dietary supplements for glycemic control.
keep in mind

Keep in Mind

  • Results may not be applicable to populations outside the study sample.
  • Further research is needed to confirm long-term effects.
  • The study did not assess the impact of lifestyle factors on outcomes.
between the lines

Between the Lines

  • The study's sample size may limit the generalizability of the findings.
  • The duration of the intervention may not reflect long-term effects.
  • The study did not measure other potential confounding factors.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Probiotics and Synbiotics and Adverse events incidence, Probiotics and Synbiotics and Fasting Glucose.

Related evidence relationships

Explore in Evidence Archive

This study contributes to the evidence on the following intervention-outcome relationships.

Included in these evidence collections

Curated evidence collections and hubs this study is part of.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Probiotics and Synbiotics improve fasting glucose?

Strong Evidence

Probiotics and Synbiotics may improve Fasting Glucose.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

  1. 1

    Fasting Plasma Glucose (FPG)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on 9 supporting studies with generally consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
9 supporting studiesUpdated: Jul 2026

Does Probiotics and Synbiotics improve HbA1c?

Strong Evidence

Probiotics and Synbiotics appears to improve HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on 10 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
10 supporting studiesUpdated: Jul 2026

Does Probiotics and Synbiotics improve adipokine and angiogenic markers?

Strong Evidence

Probiotics and Synbiotics may improve Adipokine and Angiogenic Markers.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: The available evidence reports mixed findings.

Ranked evidence signals

  1. 1

    LDL cholesterol

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

  • Population details are unavailable.
9 supporting studiesUpdated: Jul 2026

Does Centella asiatica (CA) extract affect adverse events incidence?

Emerging Evidence

Centella asiatica (CA) extract appears to improve Adverse events incidence.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Adverse events incidence

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, archive views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.